Kenneth Ogan, MD

One star
One star
One star
One star
One half star

Rating: 4.9 out of 5 (384 ratings)

Role

Urology
Specialty

Bladder Cancer Kidney (Renal) Cancer Prostate Cancer Testicular Cancer
Research Program

Discovery and Developmental Therapeutics
Practicing Since

2002

Call 404-778-4898

Background

Dr. Ogan is an Associate Professor of Urology at the Emory University School of Medicine and Co-Director of Emory Comprehensive Stone Center.

Dr. Ogan attended the University of Vermont, Burlington, VT for his undergraduate education (Bachelor in Art). He received his medical degree from New York Medical College in Valhalla, New York followed by urology residency training at George Washington University School of Medicine. Dr. Ogan completed his fellowship training in endourology, minimally invasive surgery and laparoscopy at the University of Texas Southwestern Medical Center in Dallas, Texas. Dr. Ogan is a diplomate of the American Board of Urology (2003).

Dr. Ogan clinical and research interests lie in minimally invasive therapy including laparoscopic and robotic urologic oncologic (cancer) surgery. He has pioneered various surgical techniques for laparoscopic, robotic and thermal ablation kidney cancer surgery to cure patients from cancer while preserving their kidney function. Dr. Ogan performs robotic surgery for the treatment of kidney, bladder and prostate cancer. Patients attending Emory Urology for cancer treatment have the unique opportunity to be cured of their disease while at the same time preserve their vital organs, their functionality and quality of life. As co-director of the Stone Clinic, Dr. Ogan is also involved in the prevention and endoscopic/percutaneous management of patients with kidney stones.

Dr. Ogan has lectured both nationally and internationally. He is closely involved in teaching and mentoring medical students, urology residents and post-graduate fellows. His research involves the utilization of innovative virtual reality systems to train surgeons to perform surgical procedures. Dr. Ogan’s innovative work in teaching and training surgeons is well recognized nationally. He is the recipient of the Golden Apple Teaching Award from Emory University Department of Urology in 2008 & 2012. He has authored multiple book chapters and scientific journal articles.

Titles & Roles

Professor, Department of Urology

Emory University School of Medicine
Co-Director, Emory Comprehensive Stone Center

Emory University School of Medicine

Education & Training

Education

Fellowship, Urology, 2002
UT Southwestern - Parkland Memorial Hospital
Residency, Urology, 2001
George Washington University Hospital
Medical Education, MD, 1995
New York Medical College

Board Certifications

Urology
American Board of Urology, 2004

Research

View Current Clinical Trials


ENdoluminal LIGHT ActivatED Treatment of Upper Tract Urothelial Cancer (ENLIGHTED) Study Phase III Conditions Transitional Cell Cancer of Renal Pelvis and Ureter Location Winship Cancer Institute
Perioperative Testosterone Replacement Therapy for the Improvement of Post-Operative Outcomes in Patients With Low Testosterone Phase I Conditions Hypogonadism, Malignant Urinary System Neoplasm, Urinary System Disorder, Urinary System Neoplasm Location Winship Cancer Institute

Publications

Title/Journal	Authors	Publication Date
Incidence of New Mental Health Diagnosis in Testicular Cancer Survivors. Urology	S Marthi, G Palmateer, T Helman, D Patil, E Nicaise, T Goodstein, K Ogan, V Narayan, V Master, SS Joshi	04/16/2025
Neoadjuvant cabozantinib for locally advanced nonmetastatic clear cell renal cell carcinoma: a phase 2 trial. Nature cancer	MA Bilen, BT Vo, Y Liu, R Greenwald, AH Davarpanah, D McGuire, R Shiradkar, L Li, A Midya, B Nazha, JT Brown, S Williams, W Session, G Russler, S Caulfield, SS Joshi, VM Narayan, CP Filson, K Ogan, O Kucuk, BC Carthon, L Del Balzo, A Cohen, A Boyanton, N Prokhnevska, MA Cardenas, E Sobierajska, CS Jansen, DH Patil, E Nicaise, AO Osunkoya, HT Kissick, VA Master	03/01/2025
Paraneoplastic Syndrome Prevalence and Survival in Racially-Diverse Cohort With Renal Cell Carcinoma. Clinical genitourinary cancer	EH Nicaise, BN Schmeusser, G Palmateer, K Vashi, K Parikh, D Patil, DD Shapiro, EJ Abel, S Joshi, V Narayan, K Ogan, VA Master	12/01/2024
PD-L1 and nectin-4 expression and genomic characterization of bladder cancer with divergent differentiation. Cancer	DJ Martini, KB Case, D Gratz, K Pellegrini, E Beagle, T Schneider, M Dababneh, B Nazha, JT Brown, SS Joshi, VM Narayan, K Ogan, VA Master, BC Carthon, O Kucuk, LR Harik, MA Bilen	11/01/2024
The diagnostic challenges of differentiating metastatic extramammary Paget disease and prostatic adenocarcinoma: A case report and review of the literature. Urology case reports	G Palmateer, EH Nicaise, J Gandhi, T Goodstein, M Sheng, K Ogan, O Kucuk, M Yushak, MG Sanda, KA Delman, V Master	11/01/2024
Paraneoplastic Resolution Holds Prognostic Utility in Patients with Metastatic Renal Cell Carcinoma. Cancers	G Palmateer, EH Nicaise, T Goodstein, BN Schmeusser, D Patil, N Imtiaz, DD Shapiro, EJ Abel, S Joshi, V Narayan, K Ogan, VA Master	10/30/2024
Neoadjuvant cabozantinib restores CD8+ T cells in patients with locally advanced non-metastatic clear cell renal cell carcinoma: a phase 2 trial. Research square	MA Bilen, BT Vo, Y Liu, R Greenwald, AH Davarpanah, D McGuire, R Shiradkar, L Li, B Nazha, JT Brown, S Williams, W Session, G Russler, S Caulfield, SS Joshi, VM Narayan, CP Filson, K Ogan, O Kucuk, BC Carthon, L Del Balzo, A Cohen, A Boyanton, N Prokhnevska, MA Cardenas, E Sobierajska, CS Jansen, DH Patil, E Nicaise, AO Osunkoya, H Kissick, VA Master	08/08/2024
Perioperative nivolumab versus observation in patients with renal cell carcinoma undergoing nephrectomy (PROSPER ECOG-ACRIN EA8143): an open-label, randomised, phase 3 study. The Lancet. Oncology	ME Allaf, SE Kim, V Master, DF McDermott, LC Harshman, SM Cole, CG Drake, S Signoretti, M Akgul, N Baniak, E Li-Ning, MB Palmer, H Emamekhoo, N Adra, H Kaimakliotis, Y Ged, PM Pierorazio, EJ Abel, MA Bilen, K Ogan, HH Moon, KA Ramaswamy, EA Singer, TM Mayer, J Lohrey, V Margulis, J Gills, SE Delacroix, MJ Waples, AC James, P Wang, T Choueiri, MD Michaelson, A Kapoor, DY Heng, B Shuch, BC Leibovich, PN Lara, J Manola, D Maskens, D Battle, R Uzzo, G Bratslavsky, NB Haas, MA Carducci	08/01/2024
Linear Muscle Segmentation for Metastatic Renal Cell Carcinoma: Changes in Clinic-Friendly Estimation Predict Survival Following Cytoreductive Nephrectomy. Clinical genitourinary cancer	EH Nicaise, BN Schmeusser, A Ali, E Midenberg, AR Palacios, B Hartsoe, E Kearns, S Ambadi, DH Patil, SS Joshi, VM Narayan, SP Psutka, B Nazha, JT Brown, K Ogan, MA Bilen, VA Master	06/01/2024
Differences in preoperative frailty assessment of surgical candidates by sex, age, and race. Surgery open science	EH Nicaise, G Palmateer, BN Schmeusser, C Futral, Y Liu, S Goyal, R Nabavizadeh, DA Kooby, SK Maithel, JF Sweeney, JM Sarmiento, K Ogan, VA Master	06/01/2024
A missense SNP in the tumor suppressor SETD2 reduces H3K36me3 and mitotic spindle integrity in Drosophila. Genetics	JS Brockett, T Manalo, H Zein-Sabatto, J Lee, J Fang, P Chu, H Feng, D Patil, P Davidson, K Ogan, VA Master, JG Pattaras, DL Roberts, SH Bergquist, MA Reyna, JA Petros, DA Lerit, RS Arnold	04/03/2024
2018 Leibovich prognostic model for renal cell carcinoma: Performance in a large population with special consideration of Black race. Cancer	BN Schmeusser, DH Patil, EH Nicaise, M Armas-Phan, R Nabavizadeh, VM Narayan, SS Joshi, K Ogan, AO Osunkoya, MA Bilen, VA Master	02/01/2024
Cytoreductive surgery, systemic treatment, genetic evaluation, and patient perspective in a young adult with metastatic renal cell carcinoma. CA: a cancer journal for clinicians	EH Nicaise, A Yildirim, S Sheth, E Richter, MA Daneshmand, SK Maithel, K Ogan, MA Bilen, VA Master	01/01/2024
AUTHOR REPLY. Urology	BN Schmeusser, EH Nicaise, K Ogan, VA Master	01/01/2024
Performance of Future Glomerular Filtration Rate Equation by Race in a Large, Racially Diverse Patient Cohort Undergoing Nephrectomy for Renal Cell Carcinoma. Urology	BN Schmeusser, EH Nicaise, AR Palacios, A Ali, DH Patil, M Armas-Phan, K Ogan, VA Master	01/01/2024
Creatinine to Cystatin-C Ratio in Renal Cell Carcinoma: A Clinically Pragmatic Prognostic Factor and Sarcopenia Biomarker. The oncologist	BN Schmeusser, H Biermann, EH Nicaise, AA Ali, DH Patil, E Midenberg, T Helman, M Armas-Phan, R Nabavizadeh, SS Joshi, VM Narayan, MA Bilen, SP Psutka, K Ogan, VA Master	12/11/2023
Immune-Related Adverse Events and Clinical Outcomes in Advanced Urothelial Cancer Patients Treated With Immune Checkpoint Inhibitors. The oncologist	GE Sanda, JM Shabto, S Goyal, Y Liu, DJ Martini, B Nazha, JT Brown, LB Yantorni, G Anne Russler, S Caulfield, SS Joshi, VM Narayan, H Kissick, K Ogan, VA Master, BC Carthon, O Kucuk, MA Bilen	12/11/2023
Evaluation of a Non-race-based Equation in Predicting Glomerular Filtration Rates Postnephrectomy in a Racially Diverse Cohort. Urology practice	EH Nicaise, BN Schmeusser, DH Patil, K Ogan, VA Master	11/01/2023
Reply by Authors. Urology practice	EH Nicaise, BN Schmeusser, DH Patil, K Ogan, VA Master	11/01/2023
Low Skeletal Muscle as a Risk Factor for Worse Survival in Nonmetastatic Renal Cell Carcinoma with Venous Tumor Thrombus. Clinical genitourinary cancer	BN Schmeusser, E Midenberg, AR Palacios, AA Ali, DH Patil, M Higgins, R Nabavizadeh, B Croll, M Williams, J Sheehy, B Zheng, VM Narayan, SS Joshi, K Ogan, SP Psutka, MA Bilen, VA Master	08/01/2023
Barriers and facilitators to physical activity prehabilitation in patients with kidney cancer. European journal of oncology nursing : the official journal of European Oncology Nursing Society	CM Paulo, AA Ali, BN Schmeusser, E Midenberg, TA Helman, ML Diller, MF Pisters, K Ogan, VA Master	08/01/2023
Reply to Pankaj N. Maheshwari, Aditya Goal, and Pushkar Srivastava's Letter to the Editor re: Manuel Armas-Phan, Benjamin N. Schmeusser, Nicholas W. Eyrich, and Kenneth Ogan. Double-J Stent Misplacement in the Inferior Vena Cava and Right Atrium: A Urovascular Nightmare. Eur Urol Open Sci 2022;46:128-34. European urology open science	BN Schmeusser, M Armas-Phan, NW Eyrich, K Ogan	04/01/2023
Race-free renal function estimation equations and potential impact on Black patients: Implications for cancer clinical trial enrollment. Cancer	BN Schmeusser, AR Palacios, ER Midenberg, R Nabavizadeh, DH Patil, RD Harvey, J Bryksin, MJ Connor, K Ogan, MA Bilen, VA Master	03/15/2023
Neoadjuvant Nivolumab and Ipilimumab for Nonmetastatic Renal Cell Carcinoma with Tumor Thrombus. Journal of immunotherapy and precision oncology	VA Master, BN Schmeusser, AO Osunkoya, AR Palacios, E Midenberg, L Yantorni, K Ogan, MA Bilen	02/01/2023
Mayo Adhesive Probability Score Does Not Have Prognostic Ability in Locally Advanced Renal Cell Carcinoma. Journal of kidney cancer and VHL	BN Schmeusser, TA Manalo, Y Liu, YB Shah, A Ali, M Armas-Phan, DH Patil, R Nabavizadeh, K Ogan, VA Master	01/01/2023
Prognostic Value of Sarcopenia and Albumin in the Surgical Management of Localized Renal Cell Carcinoma. Urologic oncology	E Midenberg, MI Higgins, BN Schmeusser, DH Patil, J Zaldumbide, DJ Martini, S Steele, M Williams, R Nabavizadeh, SP Psutka, K Ogan, MA Bilen, VA Master	01/01/2023
Data regarding covariates significantly associated with sarcopenia and varying albumin statuses in patients with renal cell carcinoma. Data in brief	BN Schmeusser, DH Patil, E Midenberg, MI Higgins, J Zaldumbide, DJ Martini, S Steele, M Williams, R Nabavizadeh, SP Psutka, K Ogan, MA Bilen, VA Master	12/01/2022
Double-J Stent Misplacement in the Inferior Vena Cava and Right Atrium: A Urovascular Nightmare. European urology open science	M Armas-Phan, BN Schmeusser, NW Eyrich, K Ogan	12/01/2022
Resection of retroperitoneal tumors with inferior vena cava involvement without caval reconstruction. Journal of surgical oncology	AR Palacios, BN Schmeusser, E Midenberg, D Patil, L Xie, R Nabavizadeh, K Ogan, K Cardona, SK Maithel, VA Master	12/01/2022
Association of grit and overall survival in patients undergoing nephrectomy for renal cell carcinoma. Translational andrology and urology	ER Midenberg, BN Schmeusser, A Palacios, K Larsen, DH Patil, B Petrinec, B Croll, TL Le, G Hong, FR Lin, K Jesson, G Lee, FY Kwon, K Ogan, VA Master	11/01/2022
Sarcopenia and systemic inflammation are associated with decreased survival after cytoreductive nephrectomy for metastatic renal cell carcinoma. Cancer	AI Khan, SP Psutka, DH Patil, G Hong, MA Williams, MA Bilen, A Sekhar, HT Kissick, VM Narayan, SS Joshi, K Ogan, VA Master	06/01/2022
Clinic friendly estimation of muscle composition: Preoperative linear segmentation shows overall survival correlated with muscle mass in patients with nonmetastatic renal cell carcinoma. Frontiers in oncology	BN Schmeusser, E Midenberg, AR Palacios, N Vettikattu, DH Patil, A Medline, M Higgins, M Armas-Phan, R Nabavizadeh, SS Joshi, VM Narayan, SP Psutka, K Ogan, MA Bilen, VA Master	01/01/2022
Low free testosterone is associated with increased mortality in frail surgical patients. Surgery open science	F Lin, G Hong, F Kwon, F Pirani, S Makhani, M Henry, I Cooke, R Nabavizadeh, E Midenberg, A Mehta, C Ritenour, VA Master, K Ogan	01/01/2022
Urine-Based Metabolomics and Machine Learning Reveals Metabolites Associated with Renal Cell Carcinoma Stage. Cancers	OO Bifarin, DA Gaul, S Sah, RS Arnold, K Ogan, VA Master, DL Roberts, SH Bergquist, JA Petros, AS Edison, FM Fernández	12/13/2021
Body Composition as an Independent Predictive and Prognostic Biomarker in Advanced Urothelial Carcinoma Patients Treated with Immune Checkpoint Inhibitors. The oncologist	DJ Martini, JM Shabto, S Goyal, Y Liu, TA Olsen, ST Evans, BL Magod, D Ravindranathan, JT Brown, L Yantorni, GA Russler, S Caulfield, JM Goldman, B Nazha, SS Joshi, HT Kissick, KE Ogan, WB Harris, O Kucuk, BC Carthon, VA Master, MA Bilen	12/01/2021
Small-Cell Carcinoma of the Prostate: Report of Outcomes of Localized Disease Using the National Cancer Database. Clinical genitourinary cancer	KM Xu, Y Liu, TW Gillespie, AO Osunkoya, B Carthon, MA Bilen, CP Filson, K Ogan, PR Patel, JW Shelton, O Kucuk, S Joshi, AB Jani	08/01/2021
Machine Learning-Enabled Renal Cell Carcinoma Status Prediction Using Multiplatform Urine-Based Metabolomics. Journal of proteome research	OO Bifarin, DA Gaul, S Sah, RS Arnold, K Ogan, VA Master, DL Roberts, SH Bergquist, JA Petros, FM Fernández, AS Edison	07/02/2021
Prospective Randomized Trial Comparing the Safety and Clarity of Water Versus Saline Irrigant in Ureteroscopy. European urology focus	F Pirani, SS Makhani, FY Kim, AH Lay, CB Cimmino, L Hartsell, A Spence, VA Master, K Ogan	07/01/2021
Modified Glasgow Prognostic Score associated with survival in metastatic renal cell carcinoma treated with immune checkpoint inhibitors. Journal for immunotherapy of cancer	JT Brown, Y Liu, JM Shabto, D Martini, D Ravindranathan, EE Hitron, GA Russler, S Caulfield, L Yantorni, SS Joshi, H Kissick, K Ogan, B Nazha, BC Carthon, O Kucuk, WB Harris, VA Master, MA Bilen	07/01/2021
A Helpful Tool in the Renal Surgery Armamentarium: Dorsal Lumbotomy nephrectomy for Tumor in Patients with End-Stage Renal Disease. Urology	I Cooke, S Sadruddin, D Patil, S Tripathi, R Nabavizadeh, S Joshi, V Narayan, K Ogan, VA Master	07/01/2021
Sarcopenia and modified Glasgow Prognostic Score predict postsurgical outcomes in localized renal cell carcinoma. Cancer	MI Higgins, DJ Martini, DH Patil, R Nabavizadeh, S Steele, M Williams, SS Joshi, VM Narayan, A Sekhar, SP Psutka, K Ogan, MA Bilen, VA Master	06/15/2021
Reply to Eugenio Ventimiglia, Steeve Doizi, Andrea Salonia, and Olivier Traxer's Letter to the Editor re: Farha Pirani, Salima S. Makhani, Frances Y. Kim, et al. Prospective Randomized Trial Comparing the Safety and Clarity of Water Versus Saline Irrigant in Ureteroscopy. Eur Urol Focus. In press. https://doi.org/10.1016/j.euf.2020.02.009. European urology focus	F Pirani, S Makhani, F Kim, A Lay, C Cimmino, L Hartsell, A Spence, VA Master, K Ogan	05/01/2021
Baseline Modified Glasgow Prognostic Score Associated with Survival in Metastatic Urothelial Carcinoma Treated with Immune Checkpoint Inhibitors. The oncologist	JT Brown, Y Liu, JM Shabto, DJ Martini, D Ravindranathan, EE Hitron, GA Russler, S Caulfield, LB Yantorni, SS Joshi, H Kissick, K Ogan, WB Harris, BC Carthon, O Kucuk, VA Master, MA Bilen	05/01/2021
Segmentation and Linear Measurement for Body Composition Analysis using Slice-O-Matic and Horos. Journal of visualized experiments : JoVE	S Steele, F Lin, TL Le, A Medline, M Higgins, A Sandberg, S Evans, G Hong, MA Williams, MA Bilen, S Psutka, K Ogan, VA Master	03/21/2021
Outcomes in Patients with Renal Cell Carcinoma Undergoing Inferior Vena Cava Ligation without Reconstruction versus Thrombectomy: A Retrospective, Case Controlled Study. The Journal of urology	L Xie, G Hong, R Nabavizadeh, D Patil, CG Ethun, K Ogan, SK Maithel, VA Master	02/01/2021
EDITORIAL COMMENT. Urology	R Nabavizadeh, MI Higgins, VA Master, K Ogan	02/01/2021
Overlapping Urological Surgeries at a Tertiary Academic Center. Urology	R Nabavizadeh, MI Higgins, D Patil, KC Biebighauser Bens, E Traorè, VA Master, K Ogan	02/01/2021
Transplant Radical Nephrectomy and Transplant Radical Nephroureterectomy for Renal Cancer: Postoperative and Survival Outcomes. Annals of transplantation	R Nabavizadeh, AA Noorali, SS Makhani, G Hong, S Holzman, DH Patil, FY Kim, PL Tso, NA Turgeon, K Ogan, VA Master	10/23/2020
Molecular characteristics and markers of advanced clear cell renal cell carcinoma: Pitfalls due to intratumoral heterogeneity and identification of genetic alterations associated with metastasis. International journal of urology : official journal of the Japanese Urological Association	RC Obeng, RS Arnold, K Ogan, VA Master, JG Pattaras, JA Petros, AO Osunkoya	09/01/2020
Dynamic Evaluation of the Modified Glasgow Prognostic Scale in Patients With Resected, Localized Clear Cell Renal Cell Carcinoma. Urology	D Patil, TL Le, KB Bens, M Alemozaffar, A Lay, J Pattaras, CP Filson, K Ogan, MA Bilen, VA Master	07/01/2020
Novel risk group stratification for metastatic urothelial cancer patients treated with immune checkpoint inhibitors. Cancer medicine	JM Shabto, DJ Martini, Y Liu, D Ravindranathan, J Brown, EE Hitron, GA Russler, S Caulfield, H Kissick, M Alemozaffar, K Ogan, WB Harris, VA Master, O Kucuk, BC Carthon, MA Bilen	04/01/2020
A randomized, controlled trial for transurethral treatment of bladder tumors using PlasmaButton vaporization electrode or monopolar loop electrocautery. The Canadian journal of urology	M Alemozaffar, K Ogan, CP Filson, D Patil, G Lee, DJ Canter, G Hong, VA Master	10/01/2019
MRI quantitation of abdominal skeletal muscle correlates with CT-based analysis: implications for sarcopenia measurement. Applied physiology, nutrition, and metabolism = Physiologie appliquee, nutrition et metabolisme	AI Khan, DA Reiter, A Sekhar, P Sharma, NM Safdar, DH Patil, SP Psutka, WC Small, MA Bilen, K Ogan, VA Master	08/01/2019
Obstructing Nephrolithiasis in an 84-year-old Patient With a Diaphragmatic Herniated Ureter. Urology	LE Beland, MA Henry, T Solomon, K Ogan	02/01/2019
Editorial Comment. The Journal of urology	K Ogan	04/01/2018
Cognitive Impairment and Overall Survival in Frail Surgical Patients. Journal of the American College of Surgeons	SS Makhani, FY Kim, Y Liu, Z Ye, JL Li, LM Revenig, CP Vaughan, TM Johnson, PS García, K Ogan, VA Master	11/01/2017
Intravesical rAd-IFNα/Syn3 for Patients With High-Grade, Bacillus Calmette-Guerin-Refractory or Relapsed Non-Muscle-Invasive Bladder Cancer: A Phase II Randomized Study. Journal of clinical oncology : official journal of the American Society of Clinical Oncology	ND Shore, SA Boorjian, DJ Canter, K Ogan, LI Karsh, TM Downs, LG Gomella, AM Kamat, Y Lotan, RS Svatek, TJ Bivalacqua, RL Grubb, TL Krupski, SP Lerner, ME Woods, BA Inman, MI Milowsky, A Boyd, FP Treasure, G Gregory, DG Sawutz, S Yla-Herttuala, NR Parker, CPN Dinney	10/20/2017
A Minimally Invasive Approach for Inguinal Lymphadenectomy in Melanoma and Genitourinary Malignancy: Long-Term Outcomes in an Attempted Randomized Control Trial. Annals of surgical oncology	LM Postlewait, CR Farley, ML Diller, B Martin, M Hart Squires, MC Russell, M Rizzo, K Ogan, V Master, K Delman	10/01/2017
A novel preoperative inflammatory marker prognostic score in patients with localized and metastatic renal cell carcinoma. Asian journal of urology	RR Sekar, D Patil, Y Baum, J Pearl, A Bausum, MA Bilen, O Kucuk, WB Harris, BC Carthon, M Alemozaffar, CP Filson, JG Pattaras, PT Nieh, K Ogan, VA Master	10/01/2017
Frailty and cancer: Implications for oncology surgery, medical oncology, and radiation oncology. CA: a cancer journal for clinicians	CG Ethun, MA Bilen, AB Jani, SK Maithel, K Ogan, VA Master	09/01/2017
Patient Frailty and Discharge Disposition Following Radical Cystectomy. Clinical genitourinary cancer	JA Pearl, D Patil, CP Filson, S Arya, M Alemozaffar, VA Master, K Ogan	08/01/2017
Editorial Comment. The Journal of urology	K Ogan	08/01/2017
Treatment of men with high-risk prostate cancer based on race, insurance coverage, and access to advanced technology. Urologic oncology	RS Gerhard, D Patil, Y Liu, K Ogan, M Alemozaffar, AB Jani, ON Kucuk, VA Master, TW Gillespie, CP Filson	05/01/2017
Upper pole urologist-obtained percutaneous renal access for PCNL is safe and efficacious. The Canadian journal of urology	AP Patel, D Bui, J Pattaras, K Ogan	04/01/2017
Ureteroscopy versus Shock Wave Lithotripsy: Factors Influencing Patient Treatment Preferences. Urology practice	RS Gerhard, A Shrewsberry, T Solomon, D Nickleach, Y Liu, J Pattaras, K Ogan	11/01/2016
Author Reply. Urology	MS Broggi, D Patil, Y Baum, PT Nieh, M Alemozaffar, JG Pattaras, K Ogan, VA Master	10/01/2016
Onodera's Prognostic Nutritional Index as an Independent Prognostic Factor in Clear Cell Renal Cell Carcinoma. Urology	MS Broggi, D Patil, Y Baum, PT Nieh, M Alemozaffar, JG Pattaras, K Ogan, VA Master	10/01/2016
Utility of Prostate Cancer Screening in Kidney Transplant Candidates. Journal of the American Society of Nephrology : JASN	GA Vitiello, BA Sayed, M Wardenburg, SD Perez, CG Keith, DJ Canter, K Ogan, TC Pearson, N Turgeon	07/01/2016
Frailty and one-year mortality in major intra-abdominal operations. The Journal of surgical research	JL Li, MA Henderson, LM Revenig, JF Sweeney, DA Kooby, SK Maithel, VA Master, K Ogan	06/15/2016
Safety and Efficacy of Ureteral Stent Placement at the Bedside Using Local Anesthesia. The Journal of urology	P Nourparvar, A Leung, AB Shrewsberry, AD Weiss, D Patil, H Atallah, K Ogan, KJ Carney, VA Master	06/01/2016
Major histocompatibility complex I upregulation in clear cell renal cell carcinoma is associated with increased survival. Asian journal of urology	RR Sekar, CM De La Calle, D Patil, SA Holzman, Y Baum, U Sheikh, JH Huang, AO Osunkoya, BP Pollack, HT Kissick, K Ogan, VA Master	04/01/2016
Elevated preoperative neutrophil-to-lymphocyte ratio may be associated with decreased overall survival in patients with metastatic clear cell renal cell carcinoma undergoing cytoreductive nephrectomy. Asian journal of urology	YS Baum, D Patil, JH Huang, S Spetka, M Torlak, PT Nieh, M Alemozaffar, K Ogan, VA Master	01/01/2016
C-reactive protein in urologic cancers. Molecular aspects of medicine	J Huang, Y Baum, M Alemozaffar, K Ogan, W Harris, O Kucuk, VA Master	11/01/2015
Impact of remote monitoring and supervision on resident training using new ACGME milestone criteria. The Canadian journal of urology	IJ Safir, AB Shrewsberry, IM Issa, K Ogan, CW Ritenour, J Sullivan, MM Issa	10/01/2015
Sarcomatoid urothelial carcinoma of the bladder: a contemporary clinicopathologic analysis of 37 cases. The Canadian journal of urology	N Fatima, DJ Canter, BC Carthon, O Kucuk, VA Master, PT Nieh, K Ogan, AO Osunkoya	06/01/2015
Report of a Simplified Frailty Score Predictive of Short-Term Postoperative Morbidity and Mortality. Journal of the American College of Surgeons	LM Revenig, DJ Canter, S Kim, Y Liu, JF Sweeney, JM Sarmiento, DA Kooby, SK Maithel, LL Hill, VA Master, K Ogan	05/01/2015
Nomograms incorporating serum C-reactive protein effectively predict mortality before and after surgical treatment of renal cell carcinoma. International journal of urology : official journal of the Japanese Urological Association	W Hsiao, LA Herrel, C Yu, MW Kattan, DJ Canter, BC Carthon, K Ogan, VA Master	03/01/2015
Preoperative quantification of perceptions of surgical frailty. The Journal of surgical research	LM Revenig, DJ Canter, MA Henderson, K Ogan, DA Kooby, SK Maithel, Y Liu, S Kim, VA Master	02/01/2015
High Expression of Major Histocompatibility Complex Class I in Clear Cell Renal Cell Carcinoma Is Associated with Improved Prognosis. Urologia internationalis	SA Holzman, CM de la Calle, HT Kissick, AO Osunkoya, BP Pollack, D Patil, K Ogan, VA Master	01/01/2015
von Hippel-Lindau exonic methylation analysis using MALDI-TOF mass spectrometry. The Journal of urology	F Lian, S Sreedharan, RS Arnold, VA Master, K Ogan, JG Pattaras, DL Roberts, JA Petros	11/01/2014
A prospective study examining the association between preoperative frailty and postoperative complications in patients undergoing minimally invasive surgery. Journal of endourology	LM Revenig, DJ Canter, VA Master, SK Maithel, DA Kooby, JG Pattaras, C Tai, K Ogan	04/01/2014
Renal cell carcinoma in patients with end-stage renal disease has favorable overall prognosis. Clinical transplantation	AB Shrewsberry, AO Osunkoya, K Jiang, R Westby, D Canter, J Pattaras, N Turgeon, VA Master, K Ogan	02/01/2014
External validation of the modified Glasgow prognostic score for renal cancer. Indian journal of urology : IJU : journal of the Urological Society of India	CG Tai, TV Johnson, A Abbasi, L Herrell, WB Harris, O Kucuk, DJ Canter, K Ogan, JG Pattaras, PT Nieh, VA Master	01/01/2014
Too frail for surgery? Initial results of a large multidisciplinary prospective study examining preoperative variables predictive of poor surgical outcomes. Journal of the American College of Surgeons	LM Revenig, DJ Canter, MD Taylor, C Tai, JF Sweeney, JM Sarmiento, DA Kooby, SK Maithel, VA Master, K Ogan	10/01/2013
Computed tomography based renal parenchyma volume measurements prior to renal tumor surgery are predictive of postoperative renal function. The Canadian journal of urology	B Kunzel, W Small, M Goodman, J Pattaras, V Master, K Ogan	04/01/2013
Urinary stone risk and cola consumption. Urology	L Herrel, J Pattaras, T Solomon, K Ogan	11/01/2012
Minimally invasive inguinal lymphadenectomy via endoscopic groin dissection: comprehensive assessment of immediate and long-term complications. The Journal of urology	VA Master, SM Jafri, KA Moses, K Ogan, DA Kooby, KA Delman	10/01/2012
Robotic management of benign mid and distal ureteral strictures and comparison with laparoscopic approaches at a single institution. Urology	K Baldie, J Angell, K Ogan, N Hood, JG Pattaras	09/01/2012
Functional, oncologic, and technical outcomes after endoscopic groin dissection for penile carcinoma. The Canadian journal of urology	DJ Canter, RW Dobbs, SM Jafri, LA Herrel, K Ogan, KA Delman, VA Master	08/01/2012
Health related quality of life for stone formers. The Journal of urology	M Bryant, J Angell, H Tu, M Goodman, J Pattaras, K Ogan	08/01/2012
Prospective pilot study of smoking cessation in patients undergoing urologic surgery. Urology	B Kunzel, J Cabalza, M Faurot, T Solomon, P Nieh, J Pattaras, VA Master, K Ogan	07/01/2012
Bilateral endoscopic inguinofemoral lymphadenectomy using simultaneous carbon dioxide insufflation: an initial report of a novel approach. The Canadian journal of urology	LA Herrel, RM Butterworth, SM Jafri, C Ying, KA Delman, DA Kooby, KE Ogan, DJ Canter, VA Master	06/01/2012
Initial North American experience with the use of the Olympus Button Electrode for vaporization of bladder tumors. The Canadian journal of urology	DJ Canter, K Ogan, VA Master	04/01/2012
Association of depression and urolithiasis. Urology	J Angell, M Bryant, H Tu, M Goodman, J Pattaras, K Ogan	03/01/2012
Preoperative Erythrocyte Sedimentation Rate Independently Predicts Overall Survival in Localized Renal Cell Carcinoma following Radical Nephrectomy. International journal of surgical oncology	BW Cross, TV Johnson, AB Derosa, K Ogan, JG Pattaras, PT Nieh, O Kucuk, WB Harris, VA Master	01/01/2012
Intratumor C-reactive protein as a biomarker of prognosis in localized renal cell carcinoma. The Journal of urology	TV Johnson, S Ali, A Abbasi, O Kucuk, WB Harris, K Ogan, J Pattaras, PT Nieh, FF Marshall, AO Osunkoya, VA Master	10/01/2011
Intra-tumor Doppler flow patterns do not predict malignancy of renal masses in a United States population. The Canadian journal of urology	W Hsiao, AB Shrewsberry, KA Moses, M Malek-Jones, D Baumgarten, VA Master, K Ogan	08/01/2011
Initial experience with videoscopic inguinal lymphadenectomy. Annals of surgical oncology	KA Delman, DA Kooby, M Rizzo, K Ogan, V Master	04/01/2011
Same session bilateral ureteroscopy is safe and efficacious. The Journal of urology	JM Watson, C Chang, JG Pattaras, K Ogan	01/01/2011
Estimated volume growth characteristics of renal tumors undergoing active surveillance. The Canadian journal of urology	CK Hwang, K Ogan, J Pattaras, VA Master	12/01/2010
Acute abdominal pain: is there a potential role for MRI in the setting of the emergency department in a patient with renal calculi? Journal of magnetic resonance imaging : JMRI	B Kalb, P Sharma, K Salman, K Ogan, JG Pattaras, DR Martin	11/01/2010
Postoperative better than preoperative C-reactive protein at predicting outcome after potentially curative nephrectomy for renal cell carcinoma. Urology	TV Johnson, A Abbasi, A Owen-Smith, AN Young, O Kucuk, WB Harris, AO Osunkoya, K Ogan, J Pattaras, PT Nieh, FF Marshall, VA Master	09/01/2010
The impact of income and education on dietary habits in stone formers. Urology	DT Saint-Elie, PV Patel, KA Healy, T Solomon, JG Pattaras, J Qian, VA Master, K Ogan	08/01/2010
Serum testosterone may be associated with calcium oxalate urolithogenesis. Journal of endourology	JM Watson, AB Shrewsberry, S Taghechian, M Goodman, JG Pattaras, CW Ritenour, K Ogan	07/01/2010
Feasibility of a novel approach to inguinal lymphadenectomy: minimally invasive groin dissection for melanoma. Annals of surgical oncology	KA Delman, DA Kooby, K Ogan, W Hsiao, V Master	03/01/2010
Absolute preoperative C-reactive protein predicts metastasis and mortality in the first year following potentially curative nephrectomy for clear cell renal cell carcinoma. The Journal of urology	TV Johnson, A Abbasi, A Owen-Smith, A Young, K Ogan, J Pattaras, P Nieh, FF Marshall, VA Master	02/01/2010
Leg endoscopic groin lymphadenectomy (LEG procedure): step-by-step approach to a straightforward technique. European urology	V Master, K Ogan, D Kooby, W Hsiao, K Delman	11/01/2009
Effects of obesity and weight loss in patients with nononcological urological disease. The Journal of urology	V Natarajan, V Master, K Ogan	06/01/2009
Percutaneous endoscopic holmium laser lithotripsy for management of complicated biliary calculi. JSLS : Journal of the Society of Laparoendoscopic Surgeons	K Healy, A Chamsuddin, J Spivey, L Martin, P Nieh, K Ogan	01/01/2009
Endourological management of urolithiasis in hepatically compromised patients. The Journal of urology	JG Pattaras, K Ogan, E Martinez, P Nieh	03/01/2008
Laparoscopic ureteral reimplant for distal ureteral strictures. JSLS : Journal of the Society of Laparoendoscopic Surgeons	K Ogan, JT Abbott, C Wilmot, JG Pattaras	01/01/2008

Awards

Golden Apple Teaching Award
Emory University Department of Urology (2008 & 2012)
Research Prize Essay Contest
American Urological Association (2010)
Pfizer Scholars in Urology Grant
The George Washington University School of Medicine (2001)
The Leonard Paul Wershup MD Memorial Award
New York Medical College (1995)
Junior Alpha Omega Alpha, Honor Society
New York Medical College (1994 & 1995)
New York Medical College Trustee Merit Scholarship
New York Medical College (1993 -1995)

Ratings & Reviews

Patients who are treated in outpatient and inpatient environments are eligible to receive a survey related to their individual care. Displayed ratings and reviews are displayed for Providers who have received at least 30 returned surveys over a 12-month period and are related to all Care Provider related survey questions. To help our patients better understand our Transparency program (ratings and review), the motivations behind it, how ratings are calculated, why ratings and reviews are not published for every EHC Provider, and how this information can be helpful for our patients, please click here.

4.9	One star One star One star One star One half star	Provider showed concern
4.9	One star One star One star One star One half star	Provider explained things clearly
4.9	One star One star One star One star One half star	Provider discussed treatment options
4.9	One star One star One star One star One half star	Provider included you in decisions
4.9	One star One star One star One star One half star	Likelihood of recommending this provider

View Reviews


One star One star One star One star One star	04/08/2025	Dr. Ogan is just wonderful, the best. A kind, compasionate man
One star One star One star One star One star	04/04/2025	I would most definitely recommend others.
One star One star One star One star One star	04/04/2025	Love Dr. Ogan
One star One star One star One star One star	03/25/2025	Good
One star One star One star One star One star	03/25/2025	Communicated issues very well
One star One star One star One star One star	03/21/2025	Dr. Ogan is a kind, caring and gentle surgeon who exudes confidence. I would highly recommend him to anyone, especially someone who is considering a prostatectomy!
One star One star One star One star One star	03/18/2025	Would highly recommend
One star One star One star One star One star	03/18/2025	Dr OGAN is great, keeps me alive and doing well.
One star One star One star One star One star	03/11/2025	Always superb mannerism helping patients
One star One star One star One star One star	03/06/2025	Good
One star One star One star One star One star	03/05/2025	Dr Ogan is one of a kind Health Care Provider I have ever and would continue to trust for my health care needs. Thanks, Dr Ogan for your compassionate care for me.
One star One star One star One star One star	03/04/2025	Dr O was outstanding. His presence and kind, friendly, and caring demeanor put me at ease. He was so professional and understanding He listened and allowed me to ask questions . He explained each component of the visit.He was just EPIC.
One star One star One star One star One star	02/27/2025	Exceptional interactions
One star One star One star One star One star	02/25/2025	My experience with Dr. Ogan was great. He expressed concern for my medical condition and recommended future treatment plans. I wholeheartedly recommend Dr. Ogan
One star One star One star One star One star	02/19/2025	DR. SERVICE WAS EXCELLENT
One star One star One star One star One star	02/13/2025	Dr Ogan is a giant in medicine and someone other doctors should admire. He was empathetic, listened to my questions with patience, and honest. I have never had a better experience with a physician.
One star One star One star One star One star	02/11/2025	Dr Ogan always discusses my concerns with me. I trust his judgement completely.
One star One star One star One star One star	02/09/2025	Out of 4 urologists this is the only one to give me Immediate options to alleviate my condition
One star One star One star One star One star	02/04/2025	Doctor has kept me well informed and concerned about my care and recovery
One star One star One star One star One star	02/04/2025	Dr. Ogan in my opinion is a role model for all clinicians.
One star One star One star One star One star	02/02/2025	DR OGAN HAS ALWAYS BEEN ONE OF THE BEST PYHSICANS I SEE.
One star One star One star One star One star	01/31/2025	Dr Ogan was friendly and made it easy to understand.
One star One star One star One star One star	01/30/2025	This was a Second Opinion visit. The initial visit at Wellstar left me with many questons. This consultation with Dr. Ogan cleared all of my concerns about the condition I'm dealing with. We will continue with Emory and Dr. Ogan.
One star One star One star One star One star	01/19/2025	Dr. Ogan is world class
One star One star One star One star One star	01/18/2025	He was amazing & kept everything calm, I really like that about him! God bless him OGAN
One star One star One star One star One star	01/14/2025	Dr. Ogan is an outstanding, caring physician. He is genuinely the best and has been there for me since 2019.
One star One star One star One star One star	12/25/2024	Dr Ogan and staff were excellent
One star One star One star One star One star	12/25/2024	I like my doctor he is very caring about my health doctor Orgen is a very nice person.
One star One star One star One star One star	12/24/2024	Doctor top notch
One star One star One star One star One star	12/15/2024	Physician was a very pleasant person.
One star One star One star One star One star	12/03/2024	Dr Ogan is a good doctor.
One star One star One star One star One star	11/12/2024	Liked the way that Dr Ogan explained the heath issues and the treatment options.
One star One star One star One star One star	11/12/2024	Very good
One star One star One star One star One star	11/08/2024	Dr. Ogan is very professional, very thorough, is always prepared, and knows his patients. Dr. Ogan is easy to talk to and reduces complex medical matters to clear and understandable conversation. Dr. Ogan is an accomplished surgeon.
One star One star One star One star One star	11/01/2024	Good
One star One star One star One star One star	10/21/2024	Very impressed with Dr. Ken Ogan. Was able to schedule surgery
One star One star One star One star One star	10/20/2024	He and his team are priceless!
One star One star One star One star One star	10/17/2024	Dr. Ogan is smart, kind explains well and takes good care of my problem.
One star One star One star One star One star	10/16/2024	Thank you Dr. Organ for the time you spent explaining to me the direction that will be needed for my care.
One star One star One star One star One star	10/16/2024	Dr Ogan is a very good listener and responds to my questions In a straightforward and considerate manner.
One star One star One star One star One star	09/29/2024	Dr. Ogan does a great job with explaining everything that is going on.
One star One star One star One star One star	09/25/2024	Dr. Ogan was fantastic! Very professional, but also very easy to communicate with! Listened to a lot of questions and very patiently answered them all. Very knowledgeable and explained all my options in detail.
One star One star One star One star One star	09/24/2024	Everyone was so very nice to us. They explained everything.
One star One star One star One star One star	09/24/2024	Great experience
One star One star One star One star One star	09/18/2024	My doctor is the best !
One star One star One star One star One star	09/13/2024	I'm a big fan of Dr. Ogan. He has helped me significantly and at times that were low spots in my healthcare he got me through.
One star One star One star One star One star	09/12/2024	My provider Dr. Ogan is a urological hero! He shows up every day to save and improve people's lives.
One star One star One star One star One star	08/27/2024	Thank you!
One star One star One star One star Empty star	08/17/2024	I view Dr. Ogan as being competent and value his advice and recommendations. My only issue is the time it take to see him during my visits.
One star One star One star One star One star	08/13/2024	Doctors are meeting on my treatment
One star One star One star One star One star	08/11/2024	Doctor organ and his staff is very good very good and concerned and have the answers to my questions
One star One star One star One star One star	08/08/2024	Dr. Ogan is one of the best physicians in my opinion in the Urology profession
One star One star One star One star One star	08/06/2024	I have the highest confidence in Dr. Ogan. He gives you his full attention and answers all your questions thoroughly. He truly cares about his patients.
One star One star One star One star One star	08/06/2024	Good
One star One star One star One star One star	07/28/2024	Nurse, resident and doctor were very efficient and answered all my questions.
One star One star One star One star One star	07/28/2024	Dr. Ogan is the best
One star One star One star One star One star	07/28/2024	Dr Ogan is outstanding in staying on top of my issues.
One star One star One star One star One star	07/25/2024	Very good experience.
One star One star One star One star One star	07/23/2024	Very comforting
One star One star One star One star One star	07/19/2024	Dr. Ogan is one of the best in the business.
One star One star One star One star One star	07/18/2024	Excellent excellent
One star One star One star One star One star	07/17/2024	We have already told people about Dr Ogan, the staff & Emory
One star One star One star One star One star	07/16/2024	PA and Dr Ogan beyond outstanding in understanding my Urology problem
One star One star One star One star One star	07/16/2024	Superior treatment
One star One star One star One star One star	07/12/2024	Outstanding physician
One star One star One star One star One star	06/29/2024	Not just pressing the "Very good" button because it's easy, Dr. Ogen really was very good at all of those things.
One star One star One star Empty star Empty star	06/27/2024	Very brief visit, not much conversation with the doctor
One star One star One star One star One star	06/07/2024	Excellent Doctor, Great Service
One star One star One star One star One star	05/31/2024	Excellent service
One star One star One star One star One star	05/26/2024	Dr. Ogan was very knowledgeable and direct in his estimation and opinion of my diagnosis, treatment and prognosis.
One star One star One star One star One star	05/24/2024	Very thorough reviwed my scan results and alienated worries I had
One star One star One star One star One star	05/23/2024	Dr. Ogan is a very caring person and it shows in his practice of medicine. He was very kind and compassionate.
One star One star One star One star One star	05/21/2024	It was a pleasure meeting Dr. Hogan. He was very professional, friendly and kind. He also showed a great interest in my care and that what makes the visit extremely exceptional.
One star One star One star One star One star	05/14/2024	Definitely recommend anybody to go there.